Related Experiment Video
Updated: Jul 3, 2026

Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
Beta-amyloid protein aggregation
Marcus A Etienne1, Nadia J Edwin, Jed P Aucoin
1Department of Chemistry, Louisiana State University, Baton Rouge, USA.
Abstract:
The beta-amyloid peptide aggregates via a nucleation pathway where micellar aggregates propagate to form oligomers (protofibrils), which then polymerize into insoluble fibrils. This fibrillogenic process has been linked to the pathogenesis associated with Alzheimer's disease. One purpose of this chapter is to provide a protocol for reliably producing monomeric Abeta as a starting point for physical and biological studies. Many research groups have used organic solvents to disaggregate pre-seeded Abeta in an attempt to acquire monomeric starting materials. Others have used instrumental techniques such as size exclusion chromatography to isolate monomer, structural intermediates, and fibrils and study their affects on Abeta nucleation. This chapter discusses a modified method of Abeta preparation using organic solvents followed by dissolution into aqueous phosphate buffer systems that renders monomeric Abeta starting solutions for kinetic experiments. Additionally, this chapter details a number of physical techniques such as scanning force microscopy, circular dichroism spectroscopy, transmission electron microscopy, fluorescence spectroscopy, fluorescence photobleaching recovery, and dynamic light scattering, together with physiological techniques such as cell viability assays to characterize Abeta nucleation, aggregation, and fibrillization and the potential biological activity of the various Abeta particles.
Insights
This study details a reliable method for producing monomeric beta-amyloid (Abeta) for Alzheimer's disease research. The protocol uses organic solvents and buffer systems, enabling further physical and biological characterization of Abeta aggregation.
Area of Science:
- Biochemistry
- Neuroscience
- Biophysics
Background:
- Beta-amyloid (Abeta) peptide aggregation is central to Alzheimer's disease pathogenesis.
- Understanding Abeta nucleation, oligomerization, and fibril formation is crucial.
Purpose of the Study:
- To establish a reproducible protocol for generating monomeric Abeta.
- To characterize Abeta nucleation, aggregation, and fibrillization using various techniques.
Main Methods:
- Modified Abeta preparation using organic solvents and aqueous phosphate buffers.
- Physical characterization: scanning force microscopy, circular dichroism, transmission electron microscopy, fluorescence spectroscopy, fluorescence photobleaching recovery, dynamic light scattering.
- Biological characterization: cell viability assays.
Main Results:
- A modified method yields monomeric Abeta suitable for kinetic studies.
- Comprehensive characterization of Abeta nucleation, aggregation intermediates, and fibrils.
- Assessment of the biological activity of different Abeta species.
Conclusions:
- The presented protocol reliably produces monomeric Abeta for research.
- The study provides a framework for investigating Abeta aggregation pathways and their link to Alzheimer's disease.
- Integrated physical and biological methods enable thorough Abeta characterization.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme can...

